Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionSlow Capital, Inc.
Latest Disclosed Ownership13,312 shares
Latest Disclosed Value $ 4,683,708
Slow Capital, Inc. reports 5.83% increase in ownership of AMGN / Amgen Inc.

On April 24, 2026 - Slow Capital, Inc. filed a 13F-HR form disclosing ownership of 13,312 shares of Amgen Inc. (MX:AMGN) valued at $4,683,708 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 12,579 shares of Amgen Inc.. This represents a change in shares of 5.83% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F AMGEN COM 031162100 13,312 733 5.83 4,684 13.75 0.6083
2026-01-26 2025-12-31 13F AMGEN COM 031162100 12,579 92 0.74 4,117 16.86 0.4917
2025-10-29 2025-09-30 13F AMGEN COM 031162100 12,487 266 2.18 3,524 3.25 0.4140
2025-07-23 2025-06-30 13F AMGEN COM 031162100 12,221 -476 -3.75 3,412 -13.73 0.4179
2025-05-02 2025-03-31 13F AMGEN COM 031162100 12,697 221 1.77 3,956 21.65 0.5296
2025-01-22 2024-12-31 13F AMGEN COM 031162100 12,476 -365 -2.84 3,252 -21.42 0.4603
2024-10-18 2024-09-30 13F AMGEN COM 031162100 12,841 -657 -4.87 4,137 -1.90 0.6338
2024-07-24 2024-06-30 13F AMGEN COM 031162100 13,498 -988 -6.82 4,218 2.40 0.6827
2024-04-17 2024-03-31 13F AMGEN COM 031162100 14,486 -87 -0.60 4,119 -1.88 0.6600
2024-01-31 2023-12-31 13F AMGEN COM 031162100 14,573 -171 -1.16 4,197 5.93 0.7303
2023-10-19 2023-09-30 13F AMGEN COM 031162100 14,744 791 5.67 3,963 27.93 0.7275
2023-08-09 2023-06-30 13F AMGEN COM 031162100 13,953 -318 -2.23 3,098 -10.23 0.5376
2023-04-26 2023-03-31 13F AMGEN COM 031162100 14,271 2,117 17.42 3,450 8.08 0.6454
2023-02-13 2022-12-31 13F AMGEN COM 031162100 12,154 317 2.68 3,192 19.64 0.7104
2022-10-27 2022-09-30 13F AMGEN COM 031162100 11,837 -192 -1.60 2,668 -8.85 0.5766
2022-07-28 2022-06-30 13F AMGEN COM 031162100 12,029 439 3.79 2,927 4.42 0.7107
2022-05-02 2022-03-31 13F AMGEN COM 031162100 11,590 -100 -0.86 2,803 6.58 0.5236
2022-02-08 2021-12-31 13F Amgen COM 031162100 11,690 -5,847 -33.34 2,630 -29.47 0.4495
2021-10-21 2021-09-30 13F Amgen COM 031162100 17,537 367 2.14 3,729 -10.90 0.6836
2021-07-29 2021-06-30 13F Amgen COM 031162100 17,170 2,249 15.07 4,185 12.74 0.7913
2021-05-20 2021-03-31 13F/A-1 Amgen COM 031162100 14,921 2,508 20.20 3,712 30.06 0.8055
2021-05-05 2021-03-31 13F Amgen COM 031162100 14,502 2,089 3,608 0.8784
2021-02-11 2020-12-31 13F Amgen COM 031162100 12,413 -108 -0.86 2,854 -10.34 0.6823
2020-11-04 2020-09-30 13F Amgen COM 031162100 12,521 291 2.38 3,183 10.33 0.8671
2020-08-10 2020-06-30 13F Amgen COM 031162100 12,230 57 0.47 2,885 16.90 0.8470
2020-05-12 2020-03-31 13F Amgen COM 031162100 12,173 -1,151 -8.64 2,468 -23.16 0.9318
2020-02-14 2019-12-31 13F Amgen COM 031162100 13,324 -312 -2.29 3,212 21.71 0.9931
2019-11-06 2019-09-30 13F Amgen COM 031162100 13,636 -163 -1.18 2,639 3.78 0.9332
2019-08-01 2019-06-30 13F Amgen COM 031162100 13,799 58 0.42 2,543 -2.60 1.0490
2019-05-16 2019-03-31 13F Amgen COM 031162100 13,741 140 1.03 2,611 -1.40 1.0383
2019-01-30 2018-12-31 13F Amgen COM 031162100 13,601 537 4.11 2,648 -2.22 1.2746
2018-11-14 2018-09-30 13F Amgen COM 031162100 13,064 339 2.66 2,708 15.28 1.2057
2018-08-14 2018-06-30 13F Amgen COM 031162100 12,725 3,820 42.90 2,349 54.74 1.1910
2018-05-11 2018-03-31 13F Amgen COM 031162100 8,905 -17,540 -66.33 1,518 -66.99 0.6818
2018-02-15 2017-12-31 13F Amgen COM 031162100 26,445 26,445 4,599 2.3840
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.